Posted inBiotechnology
OHSU Scientists Create Functional Human Eggs from Skin Cells
In a groundbreaking advancement that could redefine the landscape of reproductive medicine, researchers at Oregon Health & Science University (OHSU)…
Posted inBiotechnology
New Research Challenges Traditional Views on Plant Dispersal to Islands
When the volcanic island of Surtsey emerged dramatically from the North Atlantic Ocean in 1963, it presented a pristine, barren…
Posted inBiotechnology
UC Stroke Experts Explore the Role of AI in Advancing Research and Treatment
As artificial intelligence (AI) technology sees increasing adoption across various domains, the medical field, particularly in stroke treatment and research,…
Posted inBiotechnology
Craters on Melanoma Cell Surfaces Identified as Key Sites for Tumor Destruction
Recent groundbreaking research published in the prestigious journal Cell reveals a fascinating and previously uncharted feature on the surface of…
Posted inBiotechnology
Eliminating Uncertainty in Shock Wave Predictions Through Advanced Computational Modeling
Shock waves are among the most powerful and fundamental phenomena in fluid dynamics, appearing whenever an object surpasses the speed…
Posted inBiotechnology
Serum CD80 Predicts Esophageal Cancer Therapy Success
In recent advances in cancer treatment, the combination of neoadjuvant immunotherapy and chemotherapy has emerged as a powerful strategy, particularly…
Posted inBiotechnology
Xoma and Lava buyout cools with lower cash offer and closing conditions
Xoma Royalty and Lava Therapeutics are turning the temperature down, dropping both the cash per share offer and closing cash…
Posted inBiotechnology
ESMO: Pfizer sees year-long weight gain in cancer patients with wasting condition
For the second year running, Pfizer has arrived at the European Society for Medical Oncology (ESMO) conference armed with data…
Posted inBiotechnology
ESMO: Evaxion hopes cancer vax data attract partner after cash crunch forces smaller phase 2 trial
Danish vaccine developer Evaxion has released long-term data for its lead personalized cancer vaccine, with the shot scoring a 75%…
Posted inBiotechnology
ESMO: Roche wants oral SERD to benefit ‘all comers,’ unveils phase 3 breast cancer data
Roche’s giredestrant was shown to reduce the risk of breast cancer progression or death by 62% for a specific cohort…